Drew Boxler

Articles by Drew Boxler

FDA approves Recarbrio for complicated UTI and intra-abdominal infections

July 18th 2019

While the combination drug should only be used as a last resort, ob/gyns still need to be aware of its potential risk for pregnant and lactating patients.

Latest Updated Articles

FDA approves Recarbrio for complicated UTI and intra-abdominal infections
Published: July 18th 2019 | Updated:

Drew Boxler

Articles by Drew Boxler

FDA approves Recarbrio for complicated UTI and intra-abdominal infections

Latest Updated Articles

Trending on Contemporary OB/GYN

Immune response may drive pelvic floor polypropylene mesh complications

Birth defect risk not impacted by COVID-19 vaccination